Lexaria Bioscience News

EFFECT: Others

Dec 6 06:05 ET

424B3: Prospectus

Dec 5 16:59 ET

4: Statement of changes in beneficial ownership of securities-Officer CHRISTOPHER RICHARD

Dec 3 14:06 ET

DEF 14A: Definitive information statements

Nov 27 14:43 ET

S-3: Registration statement for specified transactions by certain issuers

Nov 26 16:43 ET

10-K: FY2024 Annual Report

Nov 26 13:03 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invenomic Capital Management LP(4.7%)

Nov 14 16:16 ET

PRE 14A: Preliminary proxy statements relating to merger or acquisition

Nov 12 11:42 ET

8-K: Current report

Oct 18 16:45 ET

8-K: Current report

Oct 16 17:23 ET

D: Filing D

Oct 16 15:33 ET

424B5: Prospectus

Oct 16 06:58 ET

3: Initial statement of beneficial ownership of securities-Officer Shankman Michael Elliot

Oct 2 15:49 ET

8-K: Current report

Oct 2 12:24 ET

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wayne W. Boos(3.795%)

Sep 23 13:33 ET

3: Initial statement of beneficial ownership of securities-Officer CHRISTOPHER RICHARD

Sep 5 13:12 ET

8-K: Current report

Sep 5 10:17 ET

8-K: Current report

Aug 22 13:18 ET

424B5: Prospectus

Aug 21 16:10 ET

4: Statement of changes in beneficial ownership of securities-Director TURKEL CATHERINE C.

Aug 13 10:57 ET